Vivo Capital VIII, LLC Insider Trading $ALGS Aligos Therapeutics, Inc.
Get free email notifications about insider trading for Vivo Capital VIII, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Vivo Capital VIII, LLC. Vivo Capital VIII, LLC is 10% Owner in IMPEL NEUROPHARMA INC ($IMPL) and 10% Owner in BioPharmX Corp ($TPND) and 10% Owner in Menlo Therapeutics, Inc. ($MNLO) and 10% Owner in Bolt Biotherapeutics, Inc. ($BOLT) and 10% Owner in Nabriva Therapeutics plc ($NBRV) and 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).
Vivo Capital VIII, LLC in Aligos Therapeutics, Inc.
Trading Symbol: ALGSIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Vivo Capital VIII, LLC: 10% Owner
Holdings: 1,885,611 shares
Latest Transaction: Oct 20 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Vivo Capital VIII, LLC in Aligos Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALGS, BOLT, CRNX, IMPL, NBRV, TERN, TMBR, MNLO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 30,939 | 0 | 0 | |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 224,054 | 0 | 0 | |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 72,320 | 0 | 0 | |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 523,726 | 0 | 0 | |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 260,380 | 0 | 0 | |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,885,611 | 0 | 0 | |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 15.00 | 66,733 | 1,000,995 | 430,372 | 363.6 K to 430.4 K (+18.35 %) |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 15.00 | 483,267 | 7,249,005 | 3,116,658 | 2.6 M to 3.1 M (+18.35 %) |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 30,939 | 0 | 363,639 | 332.7 K to 363.6 K (+9.30 %) |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 72,320 | 0 | 332,700 | 260.4 K to 332.7 K (+27.77 %) |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 260,380 | 0 | 260,380 | 0 to 260.4 K |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 224,054 | 0 | 2,633,391 | 2.4 M to 2.6 M (+9.30 %) |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 523,726 | 0 | 2,409,337 | 1.9 M to 2.4 M (+27.77 %) |
Oct 20 2020 | ALGS | Aligos Therapeutic ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 1,885,611 | 0 | 1,885,611 | 0 to 1.9 M |
Page: 1